Table 1. Patient and donor... | American Society of Hematology

Table 1.

Patient and donor characteristics

Characteristic	Data
Age, y, median (range)	18.6 (1.3-53.4)
No. patients younger than 20 y	47
No. patients 20 y or older	40
No. male/no. female	50/37
Ethnic origin, no. patients
White	61
Hispanic	13
African American	5
Asian	6
Unknown	2
Disease duration, mo, median (range)	14.6 (3-328)
Pretransplantation therapy
Transfusions, no. patients	87
Immunosuppression, no. patients	87
No. courses, median (range)	3 (1-11)^*
Donor age, y, median (range)	36 (18-58)
Donor sex, no. male/no. female†	51/34
Donor†/patient sex combination, no.
Female → female	21
Female → male	13
Male → male	35
Male → female	16
CMV status, no. patients
D⁺–P⁺	21
D⁺–P^–	32
D^––P^–	15
D^––P⁺	5
Other‡	14
Donor/patient HLA compatibility, no. patients
Identical	62
Nonidentical	25
Marrow cell dose, × 10⁸/kg, median (range)	3.1 (0.006-15.6)

Characteristic	Data
Age, y, median (range)	18.6 (1.3-53.4)
No. patients younger than 20 y	47
No. patients 20 y or older	40
No. male/no. female	50/37
Ethnic origin, no. patients
White	61
Hispanic	13
African American	5
Asian	6
Unknown	2
Disease duration, mo, median (range)	14.6 (3-328)
Pretransplantation therapy
Transfusions, no. patients	87
Immunosuppression, no. patients	87
No. courses, median (range)	3 (1-11)^*
Donor age, y, median (range)	36 (18-58)
Donor sex, no. male/no. female†	51/34
Donor†/patient sex combination, no.
Female → female	21
Female → male	13
Male → male	35
Male → female	16
CMV status, no. patients
D⁺–P⁺	21
D⁺–P^–	32
D^––P^–	15
D^––P⁺	5
Other‡	14
Donor/patient HLA compatibility, no. patients
Identical	62
Nonidentical	25
Marrow cell dose, × 10⁸/kg, median (range)	3.1 (0.006-15.6)

N = 87 patients.

P indicates patient; D, donor

Single agent or combination regimens, with or without hemopoietic growth factors

Unavailable in 2 donors

In 3 patients the test was indeterminate; in the remaining 11 patients the data were not available